Advertisement
News
Subscribe to MDT Magazine News

FDA Approves DaTscan to Assist in Evaluation of Neurodegenerative Movement Disorders

January 21, 2011 8:33 am | by Diagnostic Imaging | Comments

GE Healthcare announced recently that the FDA has approved the first imaging agent to help physicians in evaluating neurodegenerative movement disorders.

TOPICS:

FDA wants stricter testing for defibrillators

January 21, 2011 6:45 am | by MATTHEW PERRONE - AP Health Writer - Associated Press | Comments

The Food and Drug Administration is recommending stricter testing requirements for heart-zapping defibrillators after years of increasing problems with the emergency medical devices.Under the agency's proposal posted online Friday, makers of external defibrillators would need to submit more...

Montrealers are feeding fish Prozac

January 21, 2011 6:38 am | by EurekAlert | Comments

(University of Montreal) Around one in four Montrealers take some kind of anti-depressant, and according to new research, the drugs are passing into the waterways and affecting fish. The findings are internationally significant as the city's sewage treatment system is similar to...

TOPICS:
Advertisement

Fresenius Medical Care North America, CombiSet True Flow Series Hemodialysis Blood Tubing Set with Priming Set and Transducer Protectors for Use with the Blood Volume Monitor:...

January 21, 2011 6:36 am | by U.S. Food & Drug Administration | Comments

Kinking can cause the destruction of red blood cells which may result in serious injury and/or death.

Shareholder Letter from Chairman of China Sky One Medical

January 21, 2011 6:34 am | by Bio-Medicine.Org | Comments

HARBIN, China, Jan. 21, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced the shareholder letter from Mr....

TOPICS:

Pharmasset Prices Public Offering of Common Stock

January 21, 2011 6:34 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Jan. 21, 2011 /- Pharmasset, Inc. (Nasdaq: VRUS ) announced today the pricing of an underwritten public offering of 3,300,000 shares of its common stock at an offering price of $46.33 per share.  Of the shares being sold, Pharmasset is selling 2,300,000 shares and...

TOPICS:

Beating the Odds: Focus: HOPE Honors First Two University of Michigan Graduates

January 21, 2011 5:39 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., January 20, 2011 — It's a brave new world for newly-minted engineers. Roy Goodman and Dallas Manning navigated a demanding engineering program to become the first Focus: HOPE engineering students to graduate from the University of Michigan in December. More

Thoratec Schedules Fourth Quarter Conference Call, Webcast

January 21, 2011 5:35 am | by Bio-Medicine.Org | Comments

PLEASANTON, Calif., Jan. 21, 2011 /- Thoratec Corporation (Nasdaq: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for fiscal year 2010 on Thursday,...

TOPICS:
Advertisement

U of South Carolina, a Leader in Ultrasound Education, Hosts World Congress in Spring

January 21, 2011 5:34 am | by Bio-Medicine.Org | Comments

COLUMBIA, S.C., Jan. 21, 2011 /PRNewswire-USNewswire/ -- It's been called the stethoscope for the 21st century. Ultrasound is a valuable tool that allows doctors to diagnose and treat patients quickly and accurately. It's been around for decades, but there has been revolutionary change in...

TOPICS:

HIG Capital to buy NovaMed for $109M

January 21, 2011 4:45 am | by The Associated Press | Comments

Ambulatory surgery center operator NovaMed Inc. said Friday it agreed to be acquired by private equity investment firm H.I.G. Capital for about $109 million.Shareholders of NovaMed, which is based in Chicago, will receive $13.25 per share in cash under the agreement. That is a x2.6 percent...

European panel recommends against MS drug Fampyra

January 21, 2011 3:45 am | by The Associated Press | Comments

A European Union committee recommended against approving Biogen Idec Inc.'s multiple sclerosis drug Fampyra, saying the drug does not help patients much and its side effects outweigh its benefits.The Committee for Medical Products for Human Use said it recommended that the drug not be approved...

VIVUS Provides Regulatory Update on QNEXA NDA

January 21, 2011 3:36 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Jan. 21, 2011 /- VIVUS, Inc. (Nasdaq: VVUS ) today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug Application (NDA) for QNEXA®, an investigational drug for the treatment of obesity.  The meeting...

TOPICS:

Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)

January 21, 2011 3:35 am | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, Jan. 21, 2011 /- GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion, recommending...

TOPICS:

UMC produces customer CMOS-MEMS sensor pProducts

January 20, 2011 7:41 pm | by I-Micronews | Comments

Volume production to begin this year.

STMicroelectronics and Bluechiip to cooperate in manufacturing of unique MEMS-based tracking tags

January 20, 2011 7:41 pm | by I-Micronews | Comments

ST?s world-leading MEMS bio-sensor and actuator manufacturing expertise to bring Bluechiip?s patented tracking tag concept into mass production for healthcare and a wide range of other applications.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading